BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33626096)

  • 1. Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1.
    Nafie E; Lolarga J; Lam B; Guo J; Abdollahzadeh E; Rodriguez S; Glackin C; Liu J
    PLoS One; 2021; 16(2):e0247652. PubMed ID: 33626096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.
    Sun T; Fu J; Shen T; Lin X; Liao L; Feng XH; Xu J
    J Biol Chem; 2016 May; 291(22):11518-28. PubMed ID: 26975371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.
    Li CW; Xia W; Lim SO; Hsu JL; Huo L; Wu Y; Li LY; Lai CC; Chang SS; Hsu YH; Sun HL; Kim J; Yamaguchi H; Lee DF; Wang H; Wang Y; Chou CK; Hsu JM; Lai YJ; LaBaff AM; Ding Q; Ko HW; Tsai FJ; Tsai CH; Hortobagyi GN; Hung MC
    Cancer Res; 2016 Mar; 76(6):1451-62. PubMed ID: 26759241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.
    Yochum ZA; Cades J; Mazzacurati L; Neumann NM; Khetarpal SK; Chatterjee S; Wang H; Attar MA; Huang EH; Chatley SN; Nugent K; Somasundaram A; Engh JA; Ewald AJ; Cho YJ; Rudin CM; Tran PT; Burns TF
    Mol Cancer Res; 2017 Dec; 15(12):1764-1776. PubMed ID: 28851812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.
    Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J
    Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
    Yang WH; Su YH; Hsu WH; Wang CC; Arbiser JL; Yang MH
    Oncogene; 2016 May; 35(18):2287-98. PubMed ID: 26257063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumor cell-specific knockout of
    Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.
    Yochum ZA; Cades J; Wang H; Chatterjee S; Simons BW; O'Brien JP; Khetarpal SK; Lemtiri-Chlieh G; Myers KV; Huang EH; Rudin CM; Tran PT; Burns TF
    Oncogene; 2019 Jan; 38(5):656-670. PubMed ID: 30171258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.
    Su Q; Shen H; Gu B; Zhu N
    Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
    Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
    J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells.
    Baldini E; Cardarelli S; Campese AF; Lori E; Fallahi P; Virili C; Forte F; Pironi D; Di Matteo FM; Palumbo P; Costanzo ML; D'Andrea V; Centanni M; Sorrenti S; Antonelli A; Ulisse S
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
    Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
    Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.